Azacitidine-nivolumab combo 'encouraging' in AMLNovember 14, 2018AMLImmuno-oncologyHematologic Malignancies
10 recommendations for the Cancer MoonshotSeptember 9, 2016Health PolicyAMLImmuno-oncologyBusiness of Medicine